Skip to content

Trial Summary

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.


ANZUP 1302

ACTRN/NCT /ethics:


Scientific title:

Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Sponsor / Cooperative group:

University of Sydney

Trial & Patient Characteristics

Cancer TypeOther
Trial TypeTreatment
PhasePhase III
Age Range11-45 years
Tumour Stream Germ cell
Cancer StageLocally Recurrent or Locally Advanced
Anticipated Start Date2014-02-01
Anticipated End Date2023-07-01

Participating Hospitals

HospitalRoyal Adelaide Hospital
Clinical Trial CoordinatorAnne Milton
Phone08 7074 2342
Principal InvestigatorDr Hsiang Tan
Recruitment StatusRecruiting